Myrbetriq ER 50 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F20BC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,086
Award facts
- Contract value 100% obligated
- $10,086.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $10,086.46. This firm fixed price delivery order, with an ultimate completion date of December 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive range of medications and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. As the prime vendor under the DLA Troop Support Medical global pharmaceutical support vehicle, the company fulfills delivery orders for brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Myrbetriq ER represents one of numerous small-to-moderate value transactions executed under the broader indefinite delivery contract structure, enabling rapid and flexible pharmaceutical supply chain support across the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26F20BC?
SPE2DR26F20BC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F20BC worth?
The government has obligated $10,086 on SPE2DR26F20BC.
Is contract SPE2DR26F20BC an order under another contract?
Yes. SPE2DR26F20BC is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20BC competed?
The extent of competition for SPE2DR26F20BC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award